1NZ7 - Header Asymmetric Unit

HEADER HYDROLASE 16-FEB-03 1NZ7

TITLE POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINE TITLE 2 PHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE, TITLE 3 COMPLEXED WITH COMPOUND 19.

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE COMPND 3 1; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: PTP1B CATALYTIC DOMAIN; COMPND 6 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1B, PTP-1B; COMPND 7 EC: 3.1.3.48; COMPND 8 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN1 OR PTP1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)/PTPASE 1B; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7

KEYWDS PROTEIN TYROSINE PHOSPHATASE FOLD, OXAMIC ACID INHIBITOR KEYWDS 2 BOUND TO P-LOOP, HYDROLASE

EXPDTA X-RAY DIFFRACTION

AUTHOR Z.XIN,T.K.OOST,C.ABAD-ZAPATERO,P.J.HAJDUK,Z.PEI, AUTHOR 2 B.G.SZCZEPANKIEWICZ,C.W.HUTCHINS,S.J.BALLARON,M.A.STASHKO, AUTHOR 3 T.LUBBEN,J.M.TREVILLYAN,M.R.JIROUSEK,G.LIU

REVDAT 2 24-FEB-09 1NZ7 1 VERSN REVDAT 1 20-MAY-03 1NZ7 0

JRNL AUTH Z.XIN,T.K.OOST,C.ABAD-ZAPATERO,P.J.HAJDUK,Z.PEI, JRNL AUTH 2 B.G.SZCZEPANKIEWICZ,C.W.HUTCHINS,S.J.BALLARON, JRNL AUTH 3 M.A.STASHKO,T.LUBBEN,J.M.TREVILLYAN,M.R.JIROUSEK, JRNL AUTH 4 G.LIU JRNL TITL POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINE JRNL TITL 2 PHOSPHATASE 1B JRNL REF BIOORG.MED.CHEM.LETT. V. 13 1887 2003 JRNL REFN ISSN 0960-894X JRNL PMID 12749891 JRNL DOI 10.1016/S0960-894X(03)00302-0

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 77.5 REMARK 3 NUMBER OF REFLECTIONS : 14931 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 738 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 19247 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 920 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 48 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2301 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 215 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 0.31 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.88 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.850 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.600 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 6.370 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 8.560 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 44.76 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 901.PAR REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : 901.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUE CYS215, LISTED IN REMARK REMARK 3 500, CORRESPONDS TO THE ACTIVE SITE CYS WHICH IS KNOWN TO BE REMARK 3 IN A STRAINED CONFORMATION IN THIS CLASS OF ENZYMES.

REMARK 4 REMARK 4 1NZ7 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-03. REMARK 100 THE RCSB ID CODE IS RCSB018376.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.10 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19823 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : 0.11300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : 0.48000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2000 REMARK 200 STARTING MODEL: PDB ENTRY 1TYR AND INITIAL INTERNAL REFINEMENT REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRECIPATION BUFFER 100 MM HEPES, REMARK 280 0.2 M MAGNESIUM ACETATE, 14% PEG8000, PH 7.10, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.14500 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 70.29000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 70.29000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 35.14500 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 285 REMARK 465 SER A 286 REMARK 465 VAL A 287 REMARK 465 GLN A 288 REMARK 465 ASP A 289 REMARK 465 GLN A 290 REMARK 465 TRP A 291 REMARK 465 LYS A 292 REMARK 465 GLU A 293 REMARK 465 LEU A 294 REMARK 465 SER A 295 REMARK 465 HIS A 296 REMARK 465 GLU A 297 REMARK 465 ASP A 298 REMARK 465 LEU A 299 REMARK 465 GLU A 300 REMARK 465 PRO A 301 REMARK 465 PRO A 302 REMARK 465 PRO A 303 REMARK 465 GLU A 304 REMARK 465 HIS A 305 REMARK 465 ILE A 306 REMARK 465 PRO A 307 REMARK 465 PRO A 308 REMARK 465 PRO A 309 REMARK 465 PRO A 310 REMARK 465 ARG A 311 REMARK 465 PRO A 312 REMARK 465 PRO A 313 REMARK 465 LYS A 314 REMARK 465 ARG A 315 REMARK 465 ILE A 316 REMARK 465 LEU A 317 REMARK 465 GLU A 318 REMARK 465 PRO A 319 REMARK 465 HIS A 320 REMARK 465 ASN A 321

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 284 CA C O CB CG OD1 OD2

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 63 -97.08 -60.78 REMARK 500 PRO A 87 150.93 -45.11 REMARK 500 LYS A 131 70.38 -116.12 REMARK 500 CYS A 215 -119.70 -136.25 REMARK 500 SER A 216 -61.77 -95.73 REMARK 500 ILE A 219 -39.89 -138.06 REMARK 500 LYS A 237 -74.55 -86.91 REMARK 500 ARG A 238 168.10 -44.37 REMARK 500 ILE A 261 92.08 79.66 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 901 A 322

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NL9 RELATED DB: PDB REMARK 900 POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE INHIBITORS REMARK 900 USING A LINKED-FRAGMENT STRATEGY REMARK 900 RELATED ID: 1NNY RELATED DB: PDB REMARK 900 POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE INHIBITORS REMARK 900 USING A LINKED-FRAGMENT STRATEGYE REMARK 900 RELATED ID: 1NO6 RELATED DB: PDB REMARK 900 POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE INHIBITORS REMARK 900 USING A LINKED-FRAGMENT STRATEGYE REMARK 900 RELATED ID: 1ONY RELATED DB: PDB REMARK 900 POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINE REMARK 900 PHOSPHATASE 1B, COMPLEXED WITH COMPOUND REMARK 900 RELATED ID: 1ONZ RELATED DB: PDB REMARK 900 POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINE REMARK 900 PHOSPHATASE 1B, COMPLEXED WITH COMPOUND

DBREF 1NZ7 A 1 321 UNP P18031 PTN1_HUMAN 1 321

SEQRES 1 A 321 MET GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER SEQRES 2 A 321 GLY SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU SEQRES 3 A 321 ALA SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS SEQRES 4 A 321 ASN LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE SEQRES 5 A 321 ASP HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP SEQRES 6 A 321 TYR ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN SEQRES 7 A 321 ARG SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR SEQRES 8 A 321 CYS GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER SEQRES 9 A 321 ARG GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SEQRES 10 A 321 SER LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU SEQRES 11 A 321 LYS GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR SEQRES 12 A 321 LEU ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG SEQRES 13 A 321 GLN LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG SEQRES 14 A 321 GLU ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE SEQRES 15 A 321 GLY VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU SEQRES 16 A 321 PHE LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS SEQRES 17 A 321 GLY PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SEQRES 18 A 321 SER GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU SEQRES 19 A 321 MET ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS SEQRES 20 A 321 LYS VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU SEQRES 21 A 321 ILE GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA SEQRES 22 A 321 VAL ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER SEQRES 23 A 321 VAL GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP LEU SEQRES 24 A 321 GLU PRO PRO PRO GLU HIS ILE PRO PRO PRO PRO ARG PRO SEQRES 25 A 321 PRO LYS ARG ILE LEU GLU PRO HIS ASN

HET 901 A 322 47

HETNAM 901 2-[(4-{2-ACETYLAMINO-2-[4-(1-CARBOXY-3-METHYLSULFANYL- HETNAM 2 901 PROPYLCARBAMOYL)-BUTYLCARBAMOYL]-ETHYL}-2-ETHYL- HETNAM 3 901 PHENYL)-OXALYL-AMINO]-BENZOIC ACID

HETSYN 901 COMPOUND 19

FORMUL 2 901 C32 H40 N4 O10 S FORMUL 3 HOH *215(H2 O)

HELIX 1 1 GLU A 2 SER A 13 1 12 HELIX 2 2 SER A 15 ALA A 27 1 13 HELIX 3 3 CYS A 32 LEU A 37 1 6 HELIX 4 4 PRO A 38 ASN A 44 5 7 HELIX 5 5 PHE A 52 HIS A 54 5 3 HELIX 6 6 THR A 91 GLN A 102 1 12 HELIX 7 7 PRO A 188 GLY A 202 1 15 HELIX 8 8 GLY A 220 ARG A 238 1 19 HELIX 9 9 ASP A 240 VAL A 244 5 5 HELIX 10 10 ASP A 245 ARG A 254 1 10 HELIX 11 11 THR A 263 MET A 282 1 20

SHEET 1 A 9 ARG A 56 LYS A 58 0 SHEET 2 A 9 TYR A 66 MET A 74 -1 N ILE A 67 O ILE A 57 SHEET 3 A 9 ARG A 79 THR A 84 -1 O TYR A 81 N ILE A 72 SHEET 4 A 9 VAL A 211 HIS A 214 1 O VAL A 211 N ILE A 82 SHEET 5 A 9 GLY A 106 MET A 109 1 N VAL A 108 O VAL A 212 SHEET 6 A 9 GLU A 167 TYR A 176 1 O PHE A 174 N VAL A 107 SHEET 7 A 9 TYR A 153 ASN A 162 -1 N ASN A 162 O GLU A 167 SHEET 8 A 9 LEU A 140 ILE A 149 -1 N LYS A 141 O GLU A 161 SHEET 9 A 9 MET A 133 PHE A 135 -1 N PHE A 135 O LEU A 140 SHEET 1 B 2 MET A 114 GLU A 115 0 SHEET 2 B 2 SER A 118 LEU A 119 -1 O SER A 118 N GLU A 115

SITE 1 AC1 22 ARG A 24 SER A 28 ASP A 29 TYR A 46 SITE 2 AC1 22 ASP A 48 CYS A 215 SER A 216 ALA A 217 SITE 3 AC1 22 GLY A 218 ILE A 219 GLY A 220 ARG A 221 SITE 4 AC1 22 GLY A 259 GLN A 262 THR A 263 GLN A 266 SITE 5 AC1 22 HOH A 531 HOH A 545 HOH A 547 HOH A 548 SITE 6 AC1 22 HOH A 606 HOH A 676

CRYST1 88.840 88.840 105.435 90.00 90.00 120.00 P 31 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.011256 0.006499 0.000000 0.00000

SCALE2 0.000000 0.012998 0.000000 0.00000

SCALE3 0.000000 0.000000 0.009485 0.00000